The Galleri-Medicare study called REACH (Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity) is a non-randomized, observational study of 50,000 Medicare beneficiaries. The ...
Open-label phase Ib/II study of cetuximab (CET) plus LY3214996 with or without abemaciclib in patients (pts) with anti-EGFR-refractory metastatic colorectal cancer (mCRC). Survival of patients (pts) ...
Antibiotic management of acute uncomplicated appendicitis among children was inferior to appendectomy, a randomized non-inferiority trial showed. For nearly 850 children with available primary outcome ...
MedPage Today on MSN
Active Surveillance for DCIS Moves Closer to Standard Option but 'Not Quite There'
Large randomized trial makes case for non-inferiority versus surgery; smaller study falls ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results